Clinical research for saliva‐based therapeutic drug monitoring of linezolid
The concentrations of linezolid in plasma and saliva were similar, indicating their potential applicability in clinical settings. The monitoring of linezolid concentrations in saliva has been shown to be particularly suitable for patients receiving intravenous administration.
Authors
- Shunsuke Nashimoto (ORCID: https://orcid.org/0009-0003-1732-5733)
- Miki Komatsu (ORCID: https://orcid.org/0000-0001-5632-6737)
- Y. Inoue (ORCID: https://orcid.org/0000-0003-1286-4677)
- Tsutomu Endo (ORCID: https://orcid.org/0000-0002-2998-2242)
- Masahiko Takahata (ORCID: https://orcid.org/0000-0002-2436-2175)
- Hitoshi Kashiwagi (ORCID: https://orcid.org/0000-0001-6385-9988)
- Mitsuru Sugawara (ORCID: https://orcid.org/0000-0001-5350-2950)
- Yoh Takekuma (ORCID: https://orcid.org/0000-0002-4325-0785)
- Yuki Sato (ORCID: https://orcid.org/0000-0003-4009-4147)
Institutions
- Hokkaido University (JP)
- Hokkaido Pharmaceutical University (JP)
- Spinal Injuries Center (JP)
- Hokkaido University Hospital (JP)
- Dokkyo Medical University (JP)
Publication Details
- Journal
- British Journal of Clinical Pharmacology
- Published
- 2024-10-10
- DOI
- https://doi.org/10.1111/bcp.16278
- Citations
- 2
- Primary Topic
- Biosimilars and Bioanalytical Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.48
Funders
- Japan Society for the Promotion of Science